Načítá se...
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses a public health threat for which preventive and therapeutic agents are urgently needed. Neutralizing antibodies are a key class of therapeutics that may bridge widespread vaccination campaigns and offer a treatment solution in popula...
Uloženo v:
| Vydáno v: | Sci Transl Med |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Association for the Advancement of Science
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8284311/ https://ncbi.nlm.nih.gov/pubmed/33820835 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.abf1906 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|